Can You Stay on 0.25mg Wegovy Long-Term?

The myth: 0.25mg is a real treatment dose if tolerated well

This is a question our prescribers hear most weeks. People start Wegovy, feel fine on 0.25mg, and reasonably wonder whether staying there is safer or easier than increasing. It's a logical thought. But the premise rests on a misunderstanding of what that first dose is actually for.

0.25mg of semaglutide is not a weight-management dose. It produces very little appetite suppression at a population level, and the clinical trials that demonstrated meaningful weight loss were conducted at the maintenance doses, primarily 2.4mg, and now up to 7.2mg following the MHRA's approval of the higher-dose single-injection pen in April 2026. The NHS medicines page for semaglutide describes the starting dose specifically as an introductory step, not a treatment level. Feeling well on 0.25mg is a good sign (it suggests your body is tolerating the medicine) but tolerating a dose and benefiting from it are two different things.

The licensed schedule exists because the dose-response relationship matters. Efficacy builds as the dose climbs toward maintenance. Staying at the bottom rung doesn't represent a cautious approach to the same outcome; it represents a different, much less effective use of the medicine.

What the titration schedule actually looks like, and why it's paced the way it is

Wegovy moves through five steps: 0.25mg, then 0.5mg, 1.0mg, 1.7mg, and 2.4mg, with roughly four weeks at each level before increasing. The full breakdown of Wegovy doses covers what changes at each stage. The four-week spacing isn't arbitrary. Semaglutide slows gastric emptying and reduces appetite by acting on GLP-1 receptors; introducing that effect gradually gives the gut time to adapt and keeps nausea manageable for most people.

The clinical evidence behind Wegovy (including the STEP 1 trial published in the New England Journal of Medicine, which found an average body-weight reduction of around 15% over 68 weeks at 2.4mg) was built on participants completing that titration to maintenance. Those results don't transfer backwards to sub-therapeutic doses.

If you've been wondering how long you're supposed to stay on 0.25mg, the standard answer is four weeks only. After that, the schedule moves to 0.5mg unless your prescriber has a specific clinical reason to do otherwise. That reason needs to come from a clinician, not from a general preference to stay comfortable.

When a slower pace is genuinely appropriate, and who decides

There is a difference between staying permanently on 0.25mg and delaying a step increase by a short period while side effects settle. If nausea or digestive symptoms are persistent and disruptive, some prescribers will hold a dose for an extra week or two before moving up. That's a clinical judgement, made with knowledge of the individual patient.

What isn't appropriate is self-managing that decision indefinitely. Holding indefinitely at a sub-therapeutic dose means incurring the cost and the practical commitment of weekly injections without the meaningful clinical benefit those injections are designed to deliver. For a fuller picture of what it means to stay on a low dose of Wegovy more broadly, that page covers the clinical context across the lower end of the schedule.

People sometimes ask about staying low because they're nervous about the higher-dose side effects, which is understandable. The gastrointestinal effects of semaglutide (nausea, loose stools, reflux, constipation) tend to peak around dose increases and settle within a few weeks for most people. That pattern repeats at each step. Your prescriber can talk through how to minimise discomfort: eating smaller meals, avoiding fatty food, staying well hydrated. The answer isn't to avoid the dose; it's to manage the transition. If you're specifically asking whether you can stay on 0.5mg Wegovy, that page explains what the clinical position is at that particular step. If you're weighing up the treatment more generally, the Wegovy overview covers how the medicine works from start to maintenance.

Understanding the cost context matters too. Private Wegovy treatment is priced per month; if you'd like to think about value alongside clinical effectiveness, the Wegovy price page sets out what's typically included and what to look for. A medicine that isn't working at the dose you're taking isn't good value at any price.

If you haven't started yet and want a prescriber to assess which treatment and which titration pace suits you, start your free consultation with the nume clinical team.